Safety and Efficacy of Anecortave Acetate in Patients With Open-Angle Glaucoma

• Status: Completed
• Trial end date: 2009-07-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study was to evaluate the safety and intraocular pressure (IOP)-lowering efficacy of anecortave acetate for treatment of elevated IOP in patients with open-angle glaucoma.

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Alcon Research
• Treatments: Anecortave; Hydrocortisone

Criteria

Inclusion Criteria:

• Diagnosis of open-angle glaucoma;

• Other protocol-defined inclusion criteria may apply.

Exclusion Criteria:

• Pseudoexfoliation;

• Pigment dispersion component;

• Other protocol-defined exclusion criteria may apply.